Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Prediction Raises $4.5M

NEW YORK (GenomeWeb) – Genomic Prediction has raised $4.5 million through the sale of preferred stock in a financing round led by Nimble Ventures, the company said today. New investor PeopleFund also joined with Genomic Prediction's early investors.

The North Brunswick, New Jersey-based firm offers tests geared toward patients undergoing in vitro fertilization. It offers a next-generation sequencing-based test for chromosomal aneuploidies, gSeq, as well as an NGS-based test to screen for monogenic and polygenic diseases, EPgT. The gSeq test costs $150 per patient plus an additional $200 for each embryo that is screened, while EPgT costs $1,000, plus $400 per embryo.

The company plans to use the funding to expand its sales team and to further invest in data science. The firm received approval from the New Jersey Department of Health Clinical Laboratory Improvement Services to offer its two preimplantation genetic tests for monogenic disorders and polygenic disorders last September.

"Our cost-effective methodology of polygenic scoring builds on old technology from industrial agriculture, but we are the first in history to develop this technology to protect the human embryo," Genomic Prediction CEO Laurent Tellier said in a statement.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.